BlueWindLogo.png
First Patient in Florida Treated in Tampa in the OASIS Clinical Trial of the RENOVA iStim System for Overactive Bladder
October 20, 2020 08:50 ET | BlueWind Medical; Florida Urology Partners
TAMPA, Fla., Oct. 20, 2020 (GLOBE NEWSWIRE) -- Overactive bladder or OAB, affects millions of women of all ages, and can negatively impact nearly every aspect of daily life—from work performance to...
BlueWindLogo.png
First U.S. Patient Treated in OASIS Clinical Trial of RENOVA iStim System for Overactive Bladder
October 08, 2020 08:55 ET | BlueWind Medical
PARK CITY, Utah and OMAHA, Neb., Oct. 08, 2020 (GLOBE NEWSWIRE) -- BlueWind Medical announced today that clinical investigators in the OverActive Bladder Stimulation System Study (OASIS) of the...
BlueWindLogo.png
BlueWind Initiates U.S. Enrollment in Clinical Trial of the RENOVA iStim to Treat Overactive Bladder
August 11, 2020 09:00 ET | BlueWind Medical
PARK CITY, Utah and HERZLIYA, Israel, Aug. 11, 2020 (GLOBE NEWSWIRE) -- BlueWind Medical announced today that enrollment has commenced at U.S. sites in the Pivotal Clinical Trial of the RENOVA...